Garnet E. Peck, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Garnet E. Peck, PhD


Garnet E. Peck, PhD
Professor Emeritus of
Industrial Pharmacy
Purdue University

Garnet E. Peck is a professor emeritus and visiting professor in the department of industrial and physical pharmacy at Purdue University’s School of Pharmacy and Pharmaceutical Sciences. He received his BS (1957) in pharmacy from Ohio Northern University and MS (1959) and PhD (1962) degrees in industrial pharmacy from Purdue University. From 1962 to 1967, Peck was employed by the Mead Johnson Research Center and in 1967 he returned to Purdue University to join the department of industrial and physical pharmacy.  He was associate department head from 1989 to 1996.

Peck’s research interests include optimization of drug product design and process design, in particular those systems involving tablets, topical drug ad­sorption, flow of solid systems, dispersed systems design and evaluation, new tablet coating materials and procedures, and excipient-drug interaction. His research has resulted in more than 110 scientific publications.

Peck is a member of the APhA, the PT Section of the American Association of Pharmaceutical Scientists (AAPS), ACS, AACP, New York Academy of Science, Sigma Xi, Rho Chi, Phi Lambda Upsilon, Phi Kappa Phi and is a fellow of the AAAS, APRS, AAPS, and the American Institute of Chemists.  Peck was chairman of the IPT Section of the Academy of Pharmaceutical Sciences for 1983-84.  He was elected to the 1985-1990 United States Pharmacopeia Committee of Revision and then re-elected to the committee for 1990-1995 and 1995-2000. He was elected to the Committee of Experts, Excipients for 2000-2005. Peck is a founding member of The Catholic Academy of Science in the United States founded in 1987.

In March 1994, he was awarded by the American Pharmaceutical Association the Sidney L. Riegelman Research Achievement Award in Pharmaceutics, and he received the Pharmaceutical Technology Publishers’ Award in September 1994.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
44%
Facility/environment problems
0%
Process development problems
11%
Production equipment downtime
11%
Raw material supply problems
11%
Regulatory restrictions
0%
Business decisions to limit production
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced

Click here